These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

799 related items for PubMed ID: 10229559

  • 1. Clinical and circulatory effects of Iloprost either administered for 1 week or 4 weeks in patients with peripheral obstructive arterial disease at Leriche-Fontaine stage III.
    Arosio E, Sardina M, Prior M, De Marchi S, Zannoni M, Bianchini C.
    Eur Rev Med Pharmacol Sci; 1998; 2(2):53-9. PubMed ID: 10229559
    [Abstract] [Full Text] [Related]

  • 2. Two randomised and placebo-controlled studies of an oral prostacyclin analogue (Iloprost) in severe leg ischaemia. The Oral Iloprost in severe Leg Ischaemia Study Group.
    Eur J Vasc Endovasc Surg; 2000 Oct; 20(4):358-62. PubMed ID: 11038148
    [Abstract] [Full Text] [Related]

  • 3. Reduction of ischaemic rest pain in advanced peripheral arterial occlusive disease. A double blind placebo controlled trial with iloprost.
    Balzer K, Bechara G, Bisler H, Clevert HD, Diehm C, Heisig G, Held K, Mahfoud Y, Mörl H, Rücker G.
    Int Angiol; 1991 Oct; 10(4):229-32. PubMed ID: 1724669
    [Abstract] [Full Text] [Related]

  • 4. Short-term and long-term effects of one-week treatment with intravenous iloprost in critical limb ischemia patients (Leriche-Fontaine stage III and IV).
    Meini S, De Franco V, Auteri A, Setacci C, Di Renzo M, Pieragalli D.
    Int Angiol; 2005 Mar; 24(1):64-9. PubMed ID: 15877001
    [Abstract] [Full Text] [Related]

  • 5. Evaluation of a conservative treatment with iloprost in severe peripheral occlusive arterial disease (POAD). GISAP Study.
    Int Angiol; 1994 Mar; 13(1):70-4. PubMed ID: 7521384
    [Abstract] [Full Text] [Related]

  • 6. [Prostacyclin and pentoxifylline in the treatment of patients with inoperable occlusions of the peripheral arteries of the lower extremities].
    Maksimović ZV.
    Srp Arh Celok Lek; 1999 Mar; 127(7-8):249-53. PubMed ID: 10624398
    [Abstract] [Full Text] [Related]

  • 7. Propionyl-L-carnitine in Leriche-Fontaine stage II peripheral arterial obstructive disease.
    Allegra C, Antignani PL, Schachter I, Koverech A, Messano M, Virmani A.
    Ann Vasc Surg; 2008 Mar; 22(4):552-8. PubMed ID: 18502605
    [Abstract] [Full Text] [Related]

  • 8. [Conservative treatment of chronic obstructive arterial disease with iloprost and physical training: assessment of results in 5 years of a study with 360 patients].
    Apperti M, Masella A, Sabia D, Verde I.
    Ann Ital Chir; 2003 Mar; 74(4):453-7. PubMed ID: 14971289
    [Abstract] [Full Text] [Related]

  • 9. Outpatient treatment of severe peripheral ischemia with intravenous intermittent low-dose iloprost. An open pilot study.
    Banyai S, Jenelten R, Wagner S, Allmann J, Banyai M, Koppensteiner R.
    Int Angiol; 2002 Mar; 21(1):36-43. PubMed ID: 11941272
    [Abstract] [Full Text] [Related]

  • 10. Prospects of prostanoid therapy. Preliminary results.
    Castagno PL, Di Molfetta L, Merlo M, Barile G, Violato F, Buzzacchino A, Ponzio F.
    Minerva Cardioangiol; 2000 Mar; 48(1-2):9-18. PubMed ID: 10829583
    [Abstract] [Full Text] [Related]

  • 11. Comparison between intravenous iloprost and vasoactive drugs in limb ischemia IIB severe. A retrospective analysis.
    Di Salvo MM, Ardita G, Giani L, Mugno F, Stevenazzi F, Mazzone A.
    Minerva Cardioangiol; 2006 Jun; 54(3):377-81. PubMed ID: 16733512
    [Abstract] [Full Text] [Related]

  • 12. [A new infusion method for a prostacyclin analogue].
    Pibiri L, Petruzzo P, Angius D, Ruiu G, Polo F, Rescigno A, Brotzu G.
    Minerva Cardioangiol; 1997 Dec; 45(12):621-5. PubMed ID: 9577128
    [Abstract] [Full Text] [Related]

  • 13. [The role of iloprost in the treatment of critical ischemia of the limbs].
    Poggesi L, Comeglio M.
    Ann Ital Med Int; 1993 Oct; 8 Suppl():71S-77S. PubMed ID: 7509614
    [Abstract] [Full Text] [Related]

  • 14. Effects of iloprost on pain-free walking distance and clinical outcome in patients with severe stage IIb peripheral arterial disease: the FADOI 2bPILOT Study.
    Mazzone A, Di Salvo M, Mazzuca S, Valerio A, Gussoni G, Bonizzoni E, Campanini M, Vescovo G, Nozzoli C, FADOI 2bPILOT Study Group.
    Eur J Clin Invest; 2013 Nov; 43(11):1163-70. PubMed ID: 24102344
    [Abstract] [Full Text] [Related]

  • 15. [Tolerance and therapeutic results of iloprost in obliterative arteriopathy in lower limbs at the severe chronic ischemia stage. A retrospective study of 29 consecutive cases].
    Duthois S, Cailleux N, Lévesque H.
    J Mal Vasc; 2000 Feb; 25(1):17-26. PubMed ID: 10705132
    [Abstract] [Full Text] [Related]

  • 16. A randomized trial of intravenous iloprost (a stable prostacyclin analogue) versus lumbar sympathectomy in the management of Buerger's disease.
    Bozkurt AK, Köksal C, Demirbas MY, Erdoğan A, Rahman A, Demirkiliç U, Ustünsoy H, Metin G, Yillik L, Onol H, Cinar B, Karaçelik M, Erdinç I, Bolcal C, Sayin AG, Turkish Buerger's Disease Research Group.
    Int Angiol; 2006 Jun; 25(2):162-8. PubMed ID: 16763533
    [Abstract] [Full Text] [Related]

  • 17. Effects of a 4-week treatment with prostaglandin E1 on plasma endothelin-1 release in patients with intermittent claudication.
    Mangiafico RA, Malatino LS, Santonocito M, Messina R, Attinà T, Dell'Arte S, Sarnataro F.
    Int J Clin Pharmacol Ther; 1999 Jul; 37(7):347-51. PubMed ID: 10442509
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Microcirculation and tolerability following i.v. infusion of PGE1 and iloprost: a randomized cross-over study in patients with critical limb ischemia.
    Schellong S, Altmann E, von Bilderling P, Rudofsky G, Waldhausen P, Rogatti W.
    Prostaglandins Leukot Essent Fatty Acids; 2004 Jun; 70(6):503-9. PubMed ID: 15120713
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 40.